Contributor Nature Comms Behind the paper CCL7 as a novel biomarker and adjuvant for immunocheckpoint blockade therapy to NSCLC Bo Zhong and Man Zhang, Wuhan University /users/b9602f7c-f753-4d15-99cd-508ad390a345 Dec 01, 2020
